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People with recurrent brain 
cancer, called glioblastoma 
multiforme (GBM), typical-
ly have 12 to 18 months 
survival, but immunothera-
py – which is showing tre-
mendous promise for many 
cancers – is now being test-
ed against this cancer. The 
trial is testing a vaccine cre-




ments that restore or en-
hance the immune system’s 
natural ability to fight can-
cer. In just the past few 
years, cancer immunology 
has produced several new 
methods of treating cancer 
that increase the strength of 
immune responses against 
tumors. Maine Medical 
Center is participating in 
this phase II randomized 
trial through its participa-
tion in the Alliance for 
Clinical Trials in Oncology.   
 
“This is an extremely excit-
ing area in oncology re-
search with promising re-
sults seen in other solid tu-
mors,” says Christine Lu-
Emerson, M.D., principal 
investigator at MMC. “We 
are fortunate to be able to 
bring this study to patients 
in Maine.”  
In this national study, im-
munotherapy is used to de-
liver specific tumor treat-
ment while attempting to 
minimize toxicity. The vac-
cine is highly individualized, 
created from the patient’s 
own tumor, and it activates 
the immune system through 
several different mecha-
nisms. This trial is looking 
at whether immunotherapy 
used as adjuvant therapy (in 
addition to the primary 
therapy of surgical removal) 
and in conjunction with 
standard care (a drug called 
bevacizumab, also known 
by its brand name, Avastin) 
can extend overall survival. 
To be eligible for the study, 
patients must meet certain 
criteria. Patients are then 
randomly assigned to one 
of three groups: 1) vaccine 
administered with bevaci-
zumab 2) vaccine followed by 
bevacizumab, or 3) bevaci-
zumab therapy alone, which 
is the existing standard of 
care for recurrent glioblas-
toma.  Patients receive the 
vaccine by injection in the 
arm. 
 
Dr. Lu-Emerson expects to 
enroll just a few patients 
per year. For more infor-
mation, contact her by 
email, cluemerson@mmc.org.  
Clinical Trial Tests Immunotherapy in Recurrent Brain Cancer 
On June 1, in a ceremony 
led by Rich Petersen, 
MMC President and 
CEO, 29 dedicated em-
ployees were recognized 
for 40-plus milestone 
years of service at MMC. 
The Wall of Honor, fea-
turing honoree photos, 
was unveiled at a ceremo-
ny on our Bramhall Cam-
pus. 
 






Deborah Dambrie, Donna 
Richardson, Mary Duffy 
 
40 Years 
Janet Beecher , Debra 
Kimball, Norma Meehan 
Patricia Burnham, Deanna 
Rogers, Wanda Antone 
Jutta Nappi, Kenneth 
Sawtelle, Gayla Ames, 
Dale Ellis, Torry DiDona-
to, Suzanne Dube, Celine 
Whitehead, Cathy Hib-
bard, Marieta Atienza, 
Anh Nguyen, Elaine 
Duguay, Janet Gildard 
Cynthia Wintle, Jean Tou-
rangeau, Viola Rice, David 
MacKinnon, Nancy Stur-
devant, Stephen Snyder, 
Carole Messenger-Rioux 
Wall of  Honor Recognizes 29 Dedicated Employees 
Donna McGrew (left), of the Honor to Recognize committee, 
high fives Jutta Nappi, of our Sterile Processing Department, who 
has worked at MMC for 40 years. 
 
 
Units and departments 
across MMC are embracing 
Operational Excellence as a 
way to continuously im-
prove patient care and re-
duce waste. Here’s a look at 
some of the work units are 
doing and the Key Perfor-
mance Indicators (KPIs) 
they’re working on. 
 
NorDx Phlebotomists 
Are on Target With Blood 
Draws 
 
On May 19, Joel Botler, 
Chief Medical Officer, took 
a moment at executive hud-
dle to celebrate the phlebot-
omists of NorDx. Dr. 
Botler says he appreciates 
and values the daily status 
report provided by NorDx 
management, which in-
cludes the total number of 
patients drawn by NorDx 
phlebotomists in the previ-
ous day’s 24-hour period, 
the current day’s morning 
sweep total, and the time at 
which the morning sweep is 
complete. He noted that the 
morning sweep is consist-
ently complete by the time 
the huddle starts and added 
that this critical step is a 
huge contributor to smooth 
patient care across MMC. 
 
In the month of April the 
lab processed specimens for 
20,826 MMC patients. This 
included 3,340 patients with 
stat orders and 5,364 pa-
tients with timed orders. 
Phlebotomists draw more 
than 50 percent of the cen-
sus before 8:30 a.m. and 
commonly draw more than 
600 patients in a full day. 
 
Kudos, to the Lab as a 
whole, for all the hard work 
that leads to this success.  
 
Ambulatory Cardiac Care 
Unit (ACCU) Sees Waste 
in Disposable Blood 
Pressure Cuffs 
 
The ACCU is focusing on 
the amount of waste that 
comes from using disposa-
ble blood pressure  cuffs on 
patients who are here for a 
short period of time as op-
posed to reusable cuffs. 
This KPI fits into the waste 
category of Inventory and 
Overproduction. The unit 
has two people develop a 
new KPI every month, and 
this KPI is being led by 
Kim Illig and Trudy Kent. 
 
To collect data, we are gath-
ering all the blood pressure 
cuffs at the end of each day 
and weighing them to get a 
cumulative total of waste 
for the month. This data 
will go on the run chart. 
They’re hoping to demon-
strate the need for reusable 
BP cuffs for our same-day 
patients. 
 
P3CD “Just Do It” Pro-
motes Better Recycling 
 
Employees of P3CD are 
also trying to reduce waste. 
Betsy Audette, Nursing 
Unit Supervisor, introduced 
the idea after having a con-
versation with other unit 
employees, and recycling 
was added to their “Just Do 
It” board. 
 
While the team investigates 
more concrete ways to im-
plement recycling, employ-
ees are stepping up their 
efforts to separate trash and 
recyclables and hold each 
other accountable. They 
remove cans and bottles 
from the regular trash and 
throw them in the unit’s 
only bottle recycling con-
tainer, and make sure paper 
goes in the blue bins. 
 
“We wish we had one-
container recycling hospital 
wide,” says Michele Hig-
gins, P3CD Nurse Manager. 
“A few people want to 
make bigger changes — 
more action to come!”  
 
What’s Happening will follow 
up with the ACCU and 
P3CD to see how their pro-
jects are progressing. 
Improving Patient Care Through Operational Excellence 
OpEx Around the Hospital: KPIs, Action Items, and Just Do Its 
NorDx staff employees discuss KPI data at their daily huddle. 
Pictured (l - r): Najma Ashraf, Phlebotomist II , Liz Benham, 
Phlebotomist II, Eli Leland, Phlebotomist II , Liz Tripp, Phle-
botomist II , Kerrie Perkins Bramhall Specimen Management Su-
pervisor. 
